|
|
|
Volumn 24, Issue 2, 1997, Pages 203-218
|
|
Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 DEDIMETHYLAMINOSANCYCLINE;
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
BATIMASTAT;
CM 101;
CT 2584;
FUMAGILLOL CHLOROACETYLCARBAMATE;
ILOMASTAT;
INTERLEUKIN 12;
MARIMASTAT;
MONOCLONAL ANTIBODY LM 609;
PENTOSAN POLYSULFATE;
PRINOMASTAT;
TECOGALAN;
THALIDOMIDE;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
CANCER GROWTH;
CANCER INHIBITION;
CANCER INVASION;
CARCINOGENESIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFECT;
HUMAN;
METASTASIS POTENTIAL;
NONHUMAN;
PRIORITY JOURNAL;
TUMOR REGRESSION;
TUMOR VASCULARIZATION;
ANGIOGENESIS INDUCING AGENTS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUGS, INVESTIGATIONAL;
HUMANS;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
RECEPTORS, GROWTH FACTOR;
|
|
EID: 0030932849
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (260)
|
|
References (181)
|
